Clinical Trial Details


Back to Clinical Trials Database

Long-term survivorship challenges of advanced/metastatic GIST patients responding to Imatinib treatment: An observational study

Study documentation

Trial Status Recruiting
Dates Date of activation: 24-Mar-2021
Data management at EORTC None
Design QoL Non Mod Dev.
Not randomized / N.A.
Treatment None
Study Staff Emma Lidington (Study Coordinator) , King's College London - Division of Cancer Studies, London
Melanie Beauvois (Clinical Operations Manager) , EORTC Headquarters, Brussels
Corneel Coens (Statistician) , EORTC Headquarters, Brussels
Ingrid Desar (Study Co-Coordinator) , Radboud University Medical Center Nijmegen, Nijmegen
Francesca Martinelli (QoL Specialist) , EORTC Headquarters, Brussels
Madeline Pe (QoL Specialist) , EORTC Headquarters, Brussels
Winette van der Graaf (Study Co-Coordinator) , The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis, Amsterdam
Type of cancer Soft Tissue and Bone Sarcoma
Participating groups EORTC Quality of Life Group
EORTC Soft Tissue and Bone Sarcoma Group
Protocol summary
NCT number
Financial Support QOL Grant